A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
Clinical trial NCT05305560 · COMPLETED
Trial details
- NCT number
- NCT05305560
- Sponsor
- MedinCell S.A
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2022-09-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.